Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: Evaluating the Efficacy and Safety of Co-administrated Rosuvastatin/Ezetimibe and Telmisartan/Amlodipine [Phase 3]
Phase 3 trial assessing the efficacy and safety of co-administered Rosuvastatin/Ezetimibe with Telmisartan/Amlodipine for hypercholesterolem…
-
FDA approval · 2021-05-11FDA Approved: AVALIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for Avalide (irbesartan and hydrochlorothiazide) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2021-05-11FDA Approved: AVAPRO — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approves a supplemental application for AVAPRO (irbesartan) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Effectiveness of a mHealth Intervention for the Treatment of Depression in People With Diabetes or Hypertension in Peru [Phase 3]
Phase 3 trial evaluating a mobile health intervention for treating depression in people with diabetes or hypertension in Peru; study complet…
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Personalised Prospective Comparison of ARni With ArB in Patients With Natriuretic Peptide eLEvation [Phase 2]
Phase 2 clinical trial comparing ARni with ARB in patients with elevated natriuretic peptide; status currently UNKNOWN.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: The Effect of Sodium Reduction on Blood Pressure and Physical Function in Older Adults [NA]
Completed clinical trial evaluating sodium reduction effects on blood pressure and physical function in older adults; results posted in 2021…
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Stress Reduction and Hypertension Prevention in African Americans [Phase 2]
Phase 2 clinical trial evaluating stress reduction as a strategy for hypertension prevention in African Americans has been completed.
-
FDA approval · 2021-05-06FDA Approved: IRBESARTAN — Supplemental Application (NorthStar RxLLC)
FDA approved a supplemental application for IRBESARTAN by NorthStar RxLLC, indicating an update to the label or expanded indication.
-
FDA approval · 2021-05-06FDA Approved: IRBESARTAN — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for IRBESARTAN from Aurobindo Pharma Limited under the ANDA.
-
FDA approval · 2021-05-06FDA Approved: IRBESARTAN — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for IRBESARTAN from Camber Pharmaceuticals for the generic irbesartan product, indicating an approve…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: Denervation of the renAl sympathetIc nerveS in hearT Failure With nOrmal Lv Ejection Fraction [Phase 2, Phase 3]
A phase 2/3 clinical trial investigating denervation of the renal sympathetic nerves in heart failure with normal ejection fraction was term…
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: A Multiple Dose Study of MK-3614 (MK-3614-002) [Phase 1]
Phase 1 multiple-dose trial of MK-3614 completed with results posted.
-
FDA approval · 2021-04-30FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Zydus Lifesciences Limited)
FDA approved a supplemental application from Zydus Lifesciences Limited for a generic fixed-dose combination of candesartan cilexetil and hy…
-
FDA approval · 2021-04-30FDA Approved: CANDESARTAN CILEXETIL — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for candesartan cilexetil from Mylan Pharmaceuticals Inc.
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Physical Activity in Renal Disease (PAIRED): The Effect on Hypertension [Phase 3]
Phase 3 trial update for the PAIRED study evaluating physical activity effects on hypertension in chronic kidney disease; study terminated.
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Clarifying Optimal Sodium Intake Project [Phase 2]
A Phase 2 clinical trial update investigating optimal sodium intake for blood pressure-related conditions is completed.
-
FDA approval · 2021-04-23FDA Approved: IRBESARTAN — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
The FDA approved a supplemental application for Irbesartan from Unichem Pharmaceuticals USA, Inc., indicating regulatory approval of a modif…
-
FDA approval · 2021-04-21FDA Approved: LOTREL — Supplemental Application (Novartis Pharmaceuticals Corporation)
FDA approved a supplemental application for Lotrel (amlodipine besylate and benazepril hydrochloride) from Novartis Pharmaceuticals Corporat…
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: The Assessment of Right Ventricular Contractility in Response to Sildenafil [Phase 3]
Phase 3 clinical trial assessing right ventricular contractility response to sildenafil in hypertension was terminated.
-
FDA approval · 2021-04-16FDA Approved: CLEVIPREX — Supplemental Application (Fresenius Kabi Austria GmbH)
FDA approved a supplemental application for CLEVIPREX (clevidipine) from Fresenius Kabi Austria GmbH. The action involves a labeling/indicat…
-
FDA approval · 2021-04-08FDA Approved: NICARDIPINE HYDROCHLORIDE — Original Application (Eugia US LLC)
FDA approved Eugia US LLC's original ANDA for nicardipine hydrochloride as a generic product, enabling marketing of the generic once authori…
-
FDA label_change · 2021-04-07FDA Approved: EXFORGE — Supplemental Application (Novartis Pharmaceuticals Corporation)
The FDA approved a supplemental application for EXFORGE (amlodipine besylate and valsartan) filed by Novartis, updating the product labeling…
-
CLINICAL_TRIALS trial_result · 2021-04-06Clinical Trial Update: Duowell® vs. Telmisartan Monotherapy in Mild Dyslipidemia Patients With Hypertension [Phase 4]
Phase 4 trial evaluating Duowell® versus telmisartan monotherapy in patients with mild dyslipidemia and hypertension has completed.
-
FDA approval · 2021-04-05FDA Approved: AMLODIPINE, VALSARTAN, HYDROCHLOROTHIAZIDE — Supplemental Application (Strides Pharma Science Limited)
FDA approved a supplemental application for Strides Pharma Science Limited for a generic fixed-dose combination tablet containing amlodipine…
-
FDA approval · 2021-04-02FDA Approved: RAMIPRIL — Supplemental Application (Lupin Pharmaceuticals, Inc.)
The FDA approved Lupin Pharmaceuticals' supplemental application for ramipril (generic ACE inhibitor), enabling continued marketing with the…